Complement C3 inhibition with pegcetacoplan controls malignant effusions in recurrent ovarian cancer: Interim results from a phase II trial
Year: 2025
Type: article
Study design: Clinical Trial
Source: Gynecologic Oncology
Authors: Sarah Werner, Thejaswini Giridharan, A.N.M. Nazmul Khan, Luxue Deng, Ashley Duhon, Sora Suzuki, Celia DeJohn, Suzanne Hess, Katherine LaVigne Mager, Karen McLean, Nicole Gaulin, Peter Frederick, Brahm Segal, Emese Zsiros
Institution: Roswell Park Comprehensive Cancer Center
Language: English
Subfield: Reproductive Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4414649634